Hydronephrosis Market Report 2025

This hydronephrosis market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure.

The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology.

The increasing prevalence of kidney diseases is anticipated to drive the growth of the hydronephrosis market in the future. Kidney disease, also referred to as renal disease or nephropathy, encompasses a variety of conditions that lead to kidney damage, hindering their ability to effectively filter blood. The surge in kidney disease cases can be attributed to multiple factors, including the growing rates of diabetes and hypertension, obesity, an aging population, and both genetic and ethnic influences. Treatment for hydronephrosis focuses on addressing the underlying causes of urinary obstruction, which may involve medications, surgical procedures, or other interventions to restore normal urine flow. For example, a report published in June 2023 by Kidney Research UK, a non-profit organization based in the UK, indicated that approximately 7.2 million people in the UK are currently living with chronic kidney disease, accounting for over 10% of the population. Among these individuals, 3.25 million are in the advanced stages of the disease, while another 3.9 million are in the early stages. By 2033, it is projected that the number of individuals affected by chronic kidney disease will increase to 7.61 million. Thus, the rising incidence of kidney diseases is fueling the growth of the hydronephrosis market.

Leading companies in the hydronephrosis market are creating innovative products like drainage catheters to improve patient care by offering efficient and minimally invasive solutions for urine drainage from the kidneys. Drainage catheters are medical devices designed to extract fluids, such as urine or blood, from the body to alleviate pressure or prevent fluid buildup. For example, in October 2024, Argon Medical Devices Inc., a U.S.-based manufacturer of specialized medical products, introduced the SKATER mini-loop drainage catheter. This device is specifically designed for the minimally invasive drainage of unwanted fluid collections within the body. It is inserted through the skin with imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Renowned for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability during interventional procedures. By expanding Argon's drainage product line, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.

In October 2023, Laborie Medical Technologies Corp., a US-based diagnostic company, acquired Urotronic Inc. for an undisclosed amount. This acquisition strengthens Laborie's urology portfolio by providing innovative solutions to physicians and patients worldwide. It allows Laborie to advance cutting-edge technologies to address unmet medical needs and deliver solutions that uphold and restore human dignity. Urotronic Inc., a US-based medical device company, specializes in developing innovative treatments for urological conditions.

Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group.

North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydronephrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Hydronephrosis is a medical condition marked by the swelling of one or both kidneys due to a buildup of urine. This swelling happens when urine flow is obstructed, leading to an enlarged kidney. The obstruction can be caused by factors such as kidney stones, tumors, or anatomical abnormalities, and if not treated, it may result in kidney damage.

Hydronephrosis can be classified into two main types such as unilateral and bilateral. Unilateral hydronephrosis occurs when one kidney swells due to a blockage or other issues in the urinary tract on that side. It can be further categorized as intrinsic or extrinsic. Diagnosis typically involves laboratory tests and imaging studies. Treatment options may include shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, among others.

The hydronephrosis market research report is one of a series of new reports that provides hydronephrosis market statistics, including hydronephrosis industry global market size, regional shares, competitors with a hydronephrosis market share, detailed hydronephrosis market segments, market trends and opportunities, and any further data you may need to thrive in the hydronephrosis industry. This hydronephrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydronephrosis market includes revenues earned by entities by providing services such as urine flow monitoring, follow-up care, and minimally invasive procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.